Free Trial
NYSE:HUM

Humana Q2 2025 Earnings Report

Humana logo
$220.08 -3.47 (-1.55%)
Closing price 07/18/2025 03:59 PM Eastern
Extended Trading
$220.87 +0.79 (+0.36%)
As of 07/18/2025 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Humana EPS Results

Actual EPS
N/A
Consensus EPS
$6.32
Beat/Miss
N/A
One Year Ago EPS
N/A

Humana Revenue Results

Actual Revenue
N/A
Expected Revenue
$31.85 billion
Beat/Miss
N/A
YoY Revenue Growth
N/A

Humana Announcement Details

Quarter
Q2 2025
Time
Before Market Opens
Conference Call Date
Wednesday, July 30, 2025
Conference Call Time
8:00AM ET

Conference Call Resources

Humana Earnings Headlines

Truist Financial Lowers Humana (NYSE:HUM) Price Target to $260.00
HIDDEN IN THE BOOK OF GENESIS…
“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 trillion vault of untapped American wealth. Former CIA advisor Jim Rickards calls it the “Old Testament Wealth Code” — and says it could transform your financial future. He’s revealing everything in a new presentation.
Humana Loses Challenge to Its Medicare Rating Downgrade
Stock Movers: Charles Schwab, Robinhood, Humana
See More Humana Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Humana? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Humana and other key companies, straight to your email.

About Humana

Humana (NYSE:HUM) is a leading health and well-being company headquartered in Louisville, Kentucky, offering a comprehensive range of health insurance products and related services. The company operates through two primary segments: Retail, which delivers Medicare Advantage and prescription drug plans, and Group & Specialty, which provides employer-sponsored group health plans, Medicaid managed care services and specialty pharmacy solutions. Through these offerings, Humana serves millions of members across the United States, focusing on integrated, patient-centered care and value-based reimbursement models.

Founded in 1961 as Extendicare, the company initially focused on nursing home operations before entering the hospital business. In the 1970s, under the leadership of Dr. Wendell Cherry, the organization rebranded to Humana and expanded into for-profit hospital ownership. During the late 1990s, it divested its hospital operations to concentrate on health insurance and managed care, setting the stage for its evolution into a diversified health services provider.

Today, Humana’s product portfolio spans Medicare Advantage, Medicare Part D prescription drug coverage, Medicaid solutions and commercial plans for employer groups. The company also offers wellness and care management programs, digital health platforms and population health analytics aimed at improving clinical outcomes and reducing costs. Humana’s primary care arm, CenterWell, delivers in-home and clinic-based care, emphasizing personalized service for chronic condition management and preventive health.

Humana’s operations are predominantly U.S.-focused, with a presence in all 50 states and the District of Columbia, as well as partnerships in Puerto Rico and the U.S. Virgin Islands. Under the leadership of President and Chief Executive Officer Bruce Broussard, the company continues to prioritize member experience, clinical innovation and strategic collaborations with health systems and technology firms. Humana’s executive team and board of directors guide its mission to enhance well-being by integrating medical, behavioral and community care.

View Humana Profile

More Earnings Resources from MarketBeat